Autres langues Penumbra, Inc.

Actions

PEN

US70975L1070

Marché Fermé - Nyse Autres places de cotation 22:00:02 18/04/2024			Varia. 5j.	Varia. 1 janv.
201,8 ^USD	-3,28 %		-9,27 %	-19,76 %

28/03	Nyrada entame une étude préclinique de bonnes pratiques de laboratoire pour son candidat-médicament contre les lésions cérébrales	MT
22/03	PENUMBRA, INC. : Truist Securities toujours à l'achat	ZM

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

DiaMedica Therapeutics Launches Late-Stage Trial of Potential Stroke Treatment	17/04
EN DIRECTO DESDE LOS MERCADOS: Talgo, Telefónica, Amper, Stellantis, Eni, Amundi, EasyJet, Rheinmetall, Ericsson, Sika, Lockheed, Tesla...	16/04
Penumbra, Inc. : El desvalido de la atención sanitaria	15/04
Penumbra, Inc. : The underdog in healthcare	12/04
Penumbra, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024	09/04
Nyrada Begins Good Laboratory Practice Preclinical Study for Brain Injury Drug Candidate	28/03
North American Morning Briefing : Traders Await -2-	26/02
Traders Await Fresh Cues After Nvidia-Fueled Rally as US Equity Futures Inch Higher Pre-Bell	23/02
Penumbra Q4 Non-GAAP EPS, Revenue Increase; Shares Fall After-Hours	22/02
Penumbra: Q4 Earnings Snapshot	22/02
Earnings Flash (PEN) PENUMBRA Posts Q4 Revenue $284.7M, vs. Street Est of $286.5M	22/02
Earnings Flash (PEN) PENUMBRA Reports Q4 EPS $0.76, vs. Street Est of $0.70	22/02
Penumbra, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results	22/02
Penumbra, Inc. Provides Earnings Guidance for the Full Year 2024	22/02
Penumbra, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	22/02
Penumbra, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 22, 2024	01/02
Penumbra Illuminates Priority Dates Pre And Post-AIA	08/01
Penumbra, Inc. to Present at the J.P. Morgan 42nd Annual Healthcare Conference	19/12
Penumbra, Inc. v. RapidPulse, Inc.	14/12
First Patient in STORM-PE RCT Enrolled Evaluating Penumbra's Latest Computer Assisted Vacuum Thrombectomy, Lightning Flash, for Treatment of Acute Pulmonary Embolism	29/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Penumbra, Inc.

Actions

PEN

US70975L1070

Autres langues

Filtres